(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202409 | 202309 | % Var | 202409 | 202309 | % Var | 202403 | 202303 | % Var | |
| Sales | 3.40 | 0.84 | 304.76 | 4.19 | 1.52 | 175.66 | 5.55 | 10.19 | -45.53 |
| Other Income | 5.10 | 5.27 | -3.23 | 9.67 | 9.84 | -1.73 | 19.92 | 17.51 | 13.76 |
| PBIDT | 4.30 | 3.12 | 37.82 | 6.13 | 4.95 | 23.84 | 9.10 | 10.60 | -14.15 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 4.30 | 3.12 | 37.82 | 6.13 | 4.95 | 23.84 | 9.10 | 10.60 | -14.15 |
| Depreciation | 0.24 | 0.24 | 0.00 | 0.48 | 0.48 | 0.00 | 0.98 | 0.94 | 4.26 |
| PBT | 4.06 | 2.88 | 40.97 | 5.65 | 4.47 | 26.40 | 8.12 | 9.66 | -15.94 |
| TAX | 1.28 | 0.91 | 40.66 | 1.97 | 1.96 | 0.51 | 0.62 | 4.63 | -86.61 |
| Deferred Tax | 0.28 | 0.10 | 180.00 | 0.67 | 0.70 | -4.29 | 0.19 | 2.12 | -91.04 |
| PAT | 2.78 | 1.97 | 41.12 | 3.68 | 2.51 | 46.61 | 7.50 | 5.03 | 49.11 |
| Equity | 49.96 | 49.96 | 0.00 | 49.96 | 49.96 | 0.00 | 49.96 | 49.96 | 0.00 |
| PBIDTM(%) | 126.47 | 371.43 | -65.95 | 146.30 | 325.66 | -55.08 | 163.96 | 104.02 | 57.62 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1674.60 |
| Dr. Reddys Lab | 1221.30 |
| Cipla | 1230.85 |
| Zydus Lifesciences | 933.00 |
| Lupin | 2296.80 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: